Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury

Thrombosis and Haemostasis

Volumn 114, Issue 5, 2015, Pages 1028-1037

  Dewyer, Nicholas A ^a   El Sayed, Osama M ^a   Luke, Catherine E ^a   Elfline, Megan ^a   Kittan, Nicolai ^a   Allen, Ron ^a   Laser, Adriana ^a   Oostra, Carson ^b   Comerota, Anthony ^b   Hogaboam, Cory ^a   Kunkel, Steven L ^a   Henke, Peter K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Jobst Vascular Institute   (United States)

Author keywords

Animal models; Deep vein thrombosis; Inflammation; Venous thrombosis

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CALVASCULIN; CATHEPSIN G; CD31 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; COLLAGEN; ELASTASE; FIBRONECTIN; GELATINASE B; HIGH MOBILITY GROUP B PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; THROMBOPLASTIN; TOLL LIKE RECEPTOR 9; URIC ACID; UROKINASE; VASCULAR ENDOTHELIAL CADHERIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CULTURE; BONE MARROW DERIVED MACROPHAGE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENDOTHELIUM INJURY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR TRAP; FIBRINOLYSIS; GENE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRACELLULAR SIGNALING; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; THROMBUS; TOLL LIKE RECEPTOR 9 GENE; VEIN INJURY; VENOUS THROMBOEMBOLISM; WESTERN BLOTTING; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; DISEASE COURSE; FIBROSIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MONOCYTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VEIN; VEIN THROMBOSIS;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW CELLS; DISEASE PROGRESSION; FIBRINOLYSIS; FIBROSIS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MODELS, ANIMAL; MONOCYTES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; VEINS; VENOUS THROMBOSIS;

EID: 84946599721     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-12-1031     Document Type: Article

References (49)

1. Heit JA. The epidemiology of venous thromboembolism in the community. Ar-terioscler Thromb Vasc Biol 2008; 28: 370-372.
2. Henke PK, Comerota AJ. An update on etiology, prevention, and therapy of postthrombotic syndrome. J Vasc Surg 2011; 53: 500-509.
3. Kahn SR, Lim W, Dunn AS, et al., American College of Chest Physicians. Prevention of VTE in nonsurgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidellines. Chest 2012; 141: e195S-226S.
4. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008; 28: 387-391.
5. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289.
6. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521.
7. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein hmgb1 by ne-crotic cells triggers inflammation. Nature 2002; 418: 191-195.
8. Martinod K, Demers M, Fuchs TA, et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci USA 2013; 110: 8674-8679.
9. Brill A, Fuchs TA, Savchenko AS, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012; 10: 136-144.
10. Saha P, Humphries J, Modarai B, et al. Leukocytes and the natural history of deep vein thrombosis: Current concepts and future directions. Arterioscler Thromb Vasc Biol 2011; 31: 506-512.
11. Sindrilaru A, Peters T, Wieschalka S, et al. An unrestrained proinflammatory m1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011; 121: 985-997.
12. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
13. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-737.
14. Chen GY, Nunez G. Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826-837.
15. Henke PK, Pearce CG, Moaveni DM, et al. Targeted deletion of ccr2 impairs deep vein thombosis resolution in a mouse model. J Immunol 2006; 177: 3388-3397.
16. Henke PK, Varma MR, Moaveni DK, et al. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis. Thromb Haemost 2007; 98: 1045-1055.
17. Laser A, Elfline M, Luke C, et al. Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodelling. Arterioscler Thromb Vasc Biol 2014; 34: 377-385.
18. Deatrick KB, Luke CE, Elfline MA, et al. The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodelling. J Vasc Surg 2013; 58: 1375-1384 e1372.
19. Chen CJ, Kono H, Golenbock D, et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007; 13: 851-856.
20. Lande R, Ganguly D, Facchinetti V, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythe-matosus. Sci Transl Med 2011; 3: 73ra19.
21. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010; 32: 305-315.
22. Henke PK, Mitsuya M, Luke CE, et al. Toll-like receptor 9 signalling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol 2011; 31: 43-49.
23. Diaz JA, Obi AT, Myers DD, Jr., et al. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol 2012; 32: 556-562.
24. Deatrick KB, Eliason JL, Lynch EM, et al. Vein wall remodelling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 2005; 42: 140-148.
25. Henke PK, Varga A, De S, et al. Deep vein thrombosis resolution is modulated by monocyte cxcr2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol 2004; 24: 1130-1137.
26. Diaz JA, Hawley AE, Alvarado CM, et al. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost 2010; 104: 366-375.
27. Deatrick KB, Obi A, Luke CE, et al. Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT. Thromb Res 2013; 132: 360-366.
28. Ito T, Schaller M, Hogaboam CM, et al. Tlr9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through dc-derived notch ligand delta-like 4. J Clin Invest 2009; 119: 33-46.
29. Joshi AD, Raymond T, Coelho AL, et al. A systemic granulomatous response to schistosoma mansoni eggs alters responsiveness of bone-marrow-derived mac-rophages to toll-like receptor agonists. J Leukoc Biol 2008; 83: 314-324.
30. Sood V, Luke CE, Deatrick KB, et al. Urokinase plasminogen activator independent early experimental thrombus resolution: Mmp2 as an alternative mechanism. Thromb Haemost 2014: 1174-1183.
31. Comerota AJ, Grewal NK, Thakur S, et al. Endovenectomy of the common femoral vein and intraoperative iliac vein recanalisation for chronic iliofemoral venous occlusion. J Vasc Surg 2010; 52: 243-247.
32. Varma MR, Varga AJ, Knipp BS, et al. Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg 2003; 38: 1090-1098.
33. Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010; 107: 15880-15885.
34. Pannucci CJ, Laird S, Dimick JB, et al. A validated risk model to predict 90-day vte events in postsurgical patients. Chest 2014; 145: 567-573.
35. Massberg S, Grahl L, von Bruehl ML, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010; 16: 887-896.
36. Meissner MH, Caps MT, Bergelin RO, et al. Propagation, rethrombosis and new thrombus formation after acute deep venous thrombosis. J Vasc Surg 1995; 22: 558-567.
37. Obi AT, Diaz JA, Ballard-Lipka NL, et al. Plasminogen activator-1 overex-pression decreases experimental postthrombotic vein wall fibrosis by a non-vit-ronectin-dependent mechanism. J Thromb Haemost 2014; 12: 1353-1363.
38. Deatrick KB, Elfline M, Baker N, et al. Postthrombotic vein wall remodelling: Preliminary observations. J Vasc Surg 2011; 53: 139-146.
39. Brill A, Fuchs TA, Savchenko A, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012; 10: 136-144.
40. Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type i ifn production in pediatric systemic lupus erythematosus. Sci Transl Med 2011; 3: 73ra20.
41. Guiducci C, Tripodo C, Gong M, et al. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via tlr7 and tlr9. J Exp Med 2010; 207: 2931-2942.
42. Faraday N, Schunke K, Saleem S, et al. Cathepsin g-dependent modulation of platelet thrombus formation in vivo by blood neutrophils. PloS one 2013; 8: e71447.
43. Gould TJ, Vu TT, Swystun LL, et al. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol 2014; 34: 1977-1984.
44. Ammollo CT, Semeraro F, Xu J, et al. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein c activation. J Thromb Haemost 2011; 9: 1795-1803.
45. von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-835.
46. Dewyer NA, Sood V, Lynch EM, et al. Plasmin inhibition increases mmp-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res 2007; 142: 357-363.
47. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE, Jr. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18: 596-605; discussion 606-608.
48. Baldwin JF, Sood V, Elfline MA, et al. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodelling in experimental deep vein thrombosis. J Vasc Surg 2012; 56: 1089-1097.
49. Imaeda AB, Watanabe A, Sohail MA, et al. Acetaminophen-induced hepatotox-icity in mice is dependent on tlr9 and the nalp3 inflammasome. J Clin Invest 2009; 119: 305-314.